1. Home
  2. WEAV vs TBPH Comparison

WEAV vs TBPH Comparison

Compare WEAV & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEAV
  • TBPH
  • Stock Information
  • Founded
  • WEAV 2011
  • TBPH 2013
  • Country
  • WEAV United States
  • TBPH United States
  • Employees
  • WEAV N/A
  • TBPH N/A
  • Industry
  • WEAV EDP Services
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • WEAV Technology
  • TBPH Health Care
  • Exchange
  • WEAV Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • WEAV 600.1M
  • TBPH 699.0M
  • IPO Year
  • WEAV 2021
  • TBPH N/A
  • Fundamental
  • Price
  • WEAV $6.65
  • TBPH $14.85
  • Analyst Decision
  • WEAV Strong Buy
  • TBPH Strong Buy
  • Analyst Count
  • WEAV 5
  • TBPH 4
  • Target Price
  • WEAV $12.20
  • TBPH $23.00
  • AVG Volume (30 Days)
  • WEAV 1.2M
  • TBPH 300.8K
  • Earning Date
  • WEAV 10-30-2025
  • TBPH 11-10-2025
  • Dividend Yield
  • WEAV N/A
  • TBPH N/A
  • EPS Growth
  • WEAV N/A
  • TBPH N/A
  • EPS
  • WEAV N/A
  • TBPH 0.26
  • Revenue
  • WEAV $229,790,000.00
  • TBPH $77,205,000.00
  • Revenue This Year
  • WEAV $19.19
  • TBPH $79.82
  • Revenue Next Year
  • WEAV $15.09
  • TBPH N/A
  • P/E Ratio
  • WEAV N/A
  • TBPH $58.43
  • Revenue Growth
  • WEAV 17.34
  • TBPH 24.49
  • 52 Week Low
  • WEAV $6.35
  • TBPH $7.90
  • 52 Week High
  • WEAV $17.63
  • TBPH $15.34
  • Technical
  • Relative Strength Index (RSI)
  • WEAV 46.26
  • TBPH 59.99
  • Support Level
  • WEAV $6.41
  • TBPH $14.42
  • Resistance Level
  • WEAV $7.51
  • TBPH $15.26
  • Average True Range (ATR)
  • WEAV 0.33
  • TBPH 0.45
  • MACD
  • WEAV 0.01
  • TBPH 0.06
  • Stochastic Oscillator
  • WEAV 23.18
  • TBPH 72.59

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue from subscription services.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: